LIVER DISEASE

Soft Drinks and Nonalcoholic Fatty Liver Disease

Soft Drinks and Nonalcoholic Fatty Liver Disease

Non-alcoholic fatty liver (NASH) is an under recognized manifestation of the metabolic syndrome. The term refers to a spectrum of fatty liver that occurs in the absence of significant alcohol consumption. On the "benign" end of the spectrum, most patients with NASH fatty liver alone (simple fatty liver) have. Only a small proportion (10%) has also called functions of the liver cell injury and fibrosis, nonalcoholic steatohepatitis (NASH). This distinction between simple steatosis and NASH is important because the natural history of these categories is significantly different. Patients with simple steatosis usually have a benign prognosis from the viewpoint of liver disease (1-4). In contrast, can be up to 20% of patients with NASH ultimately develop advanced liver disease (1, 3-5). The prognosis of NASH-related cirrhosis is poor: It leads to liver failure or liver-related death in about one third of cases (6, 7). Liver cancer is a recently recognized complication of NASH-related cirrhosis.

The author William Nseir, Fares Nassar and Nimer Assy presented their point of view in the article entitled "Soft drinks consumption and non-alcoholic fatty liver". Here I am the main points of the article for my readers. The authors claim that alcoholic fatty liver (NASH) a significant health problem affecting 20% -30% of the adult population. NAFLD to nonalcoholic steatohepatitis (NASH), fatty liver hepatitis progress. This form of liver injury with a 20% -50% risk of progressive fibrosis, 30% risk of liver cirrhosis and 5% risk of hepatocellular carcinoma. Although the underlying mechanisms remain unclear progression of the disease, insulin resistance and obesity-inflammation are thought to play a key role, together with possible genetic, nutritional and lifestyle factors. The increasing prevalence of obesity in today's generation is in addition to many ...